DAMAI ENT (01060) saw its stock price soar by 5.32% in the pre-market trading session, reaching HKD 0.99, following a positive profit alert issued by the company. The surge in stock price was accompanied by a substantial turnover of HKD 50.54 million, indicating strong investor interest.

The entertainment company announced on November 6 that it anticipates its attributable net profit for the six months ending September 30, 2025, to be no less than RMB 500 million. This represents a significant increase from the RMB 337 million reported in the same period last year, showcasing the company's strong financial performance and growth trajectory.

The improved financial outlook is primarily attributed to the robust performance of DAMAI ENT's Aliyu business, which experienced substantial year-on-year growth in both revenue and profit. Additionally, the company's efforts to optimize its asset structure have led to reduced investment portfolio risk exposure and narrower investment losses compared to the previous year. With a strong cash position, DAMAI ENT plans to diversify its investments in the entertainment industry, potentially fueling further growth in the medium to long term.